Medizinische Universität Graz - Research portal

Go directly to the nagivation.
Go directly to the content.

Print view.
German.
Contact.
Data entry.
Start.
Open Access.

Navigation/Search

Researchers.
Institutions.
Projects.
Publications.
Partners.
Sponsors.
Equipment.
Knowhow.
Fields of Research.

Selected Publication:

Singer, CF; Hlauschek, D; Egle, D; Bago-Horvath, Z; Pfeiler, G; Brunner, C; Peters-Engl, C; Petru, E; Reimer, DU; Pusch, R; Seifert, M; Pichler, P; Suppan, C; Reiner, A; Greil, R; Tan, YY; Bartsch, R; Knoll, K; Kermanidis, AS; Gnant, M.
Prospective randomized phase II trial to assess the efficacy and safety of neo-adjuvant olaparib/carboplatin (OC) in comparison to docetaxel/epirubicin/cyclophosphamide (TAC) in patients with early triple-negative breast cancer (TNBC) with homologous recombination deficiency (HRD): Primary results from the ABCSG 45 trial.
J CLIN ONCOL. 2025; 43(16_SUPPL): 510 Doi: 10.1200/JCO.2025.43.16_suppl.510
Web of Science FullText FullText_MUG

Authors Med Uni Graz:: Petru Edgar; Suppan Christoph
Altmetrics:
Dimensions Citations:
Plum Analytics:
Scite (citation analytics):